Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT03028532
Eligibility Criteria:
Inclusion Criteria:
\- Active males who engage in regular exercise between the ages of 18 and 40 on the day of enrollment
• For this study, regular exercise is defined as: physical activity resulting in an increased heart rate for at least 30 minutes per day, 4-5 days per week.
Exclusion Criteria:
* Individuals outside of the described age range on the day of enrollment
* Individuals who are in a Registered Testing Pool for anti-doping purposes, or individuals who for any reason could be subject to doping control testing
* Individuals who are unwilling or unable to provide blood or urine samples
* Individuals who do not actively exercise
* Individuals with any history of cancer, cardiovascular disease, endocrine abnormalities, infertility, hypoandrogenism, renal disease, hepatic disease, neurologic disease, or any psychiatric history
* Individuals who have previously used anabolic steroids, selective estrogen receptor modulators (SERMs), selective androgen receptor modulators (SARMs), or who are currently using any substances included on the WADA Prohibited List
* History of venous thromboembolic disease (i.e. deep vein thrombosis or pulmonary embolism)
* History of untreated cataracts
* History of intracranial lesions such as pituitary tumors
* Transaminase elevation greater than 3 times the upper limit of normal (ULN)
* Moderate or heavy alcohol intake
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT03028532
Study Brief:
Protocol Section:
NCT03028532